Penserra Capital Management LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,130,000
+2073.1%
7,317
+1825.5%
0.02%
+2300.0%
Q3 2021$52,000
+6.1%
3800.0%0.00%0.0%
Q2 2021$49,000
-98.0%
380
-97.7%
0.00%
-97.8%
Q1 2021$2,490,000
+6816.7%
16,338
+4315.7%
0.05%
+4500.0%
Q4 2020$36,000
+176.9%
370
+168.1%
0.00%
Q3 2020$13,000
-99.9%
138
-99.8%
0.00%
-100.0%
Q3 2018$20,177,000
+37.8%
73,513
+4.0%
1.24%
+33.9%
Q2 2018$14,645,000
+106.9%
70,692
+65.0%
0.92%
+38.3%
Q1 2018$7,077,00042,8540.67%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders